A group of 40 dedicated employees from Novartis Canada arrived back at the Novartis Pharmaceuticals Canada Inc. headquarters in Dorval on Tuesday, Sept. 20, ending their 12th annual three and a half-day, 600 km bike ride from Toronto to Montreal for charity.
The employees on the annual Ride for Life left Toronto on Saturday, Sept. 17, and on their return it was announced they had raised $80,333 for the 
(CBCF) as part of the CIBC Run for the Cure initiative, benefiting the Quebec Breast Cancer Foundation.
Since starting this initiative in 2005, Novartis employees have raised over $1 million dollars, making them the one of the largest fundraising teams in Quebec, according to the CBCF.
“The Ride for Life is a great corporate initiative that truly shows our continued commitment to breast cancer research and our dedication to patients,” said Winselow Tucker, General Manager, Novartis Oncology Canada. “We are all inspired by the motivation and determination of all the participants this year and so proud to be one of the top fundraisers for the Run for the Cure.”
On hand to greet the riders and accept their generous donation were Nathalie Tremblay, CEO, Quebec Breast Cancer Foundation, and Karine Iseult-Ippersiel, Vice-President of Business Development and Strategy, Quebec Breast Cancer Foundation.
The Ride for Life is the Novartis team’s iteration of the CIBC Run for the Cure. Novartis Pharmaceuticals Canada Inc. holds this fundraising activity in advance of the Run, which will take place on Sunday, October 2, 2016, in more than 60 communities across Canada. The CIBC Run for the Cure is the biggest volunteer-run fundraising event in the fight against breast cancer. To contribute to this cause or to learn more, please visit cibcrunforthecure.supportcbcf.com. 
Since 1992, the annual Canadian Breast Cancer Foundation CIBC Run for the Cure has been the largest, single-day, volunteer-led national event in support of creating a future without breast cancer. On October 2, 2016, this national movement will again connect participants and volunteers in over 60 communities across the country. For more information, visit www.cibcrunforthecure.com.
The Quebec Breast Cancer Foundation is a non-profit organization devoted entirely to the fight against breast cancer through research and innovation, raising awareness, and by providing education and support to those affected by the disease and their loved ones. For more information, visit their website at www.rubanrose.org.
Novartis Pharmaceuticals Canada Inc., a leader in the healthcare field, is committed to the discovery, development and marketing of innovative products to improve the well-being of all Canadians. In 2015, the company invested $53 million in research and development in Canada. Located in Dorval, Quebec, Novartis Pharmaceuticals Canada Inc. employs more than 700 people in Canada and is an affiliate of Novartis AG, which provides innovative healthcare solutions that address the evolving needs of patients and societies. For further information, please consult www.novartis.ca.
